Pear Therapeutics Inc
NASDAQ:PEAR
Pear Therapeutics Inc
Operating Expenses
Pear Therapeutics Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Pear Therapeutics Inc
NASDAQ:PEAR
|
Operating Expenses
-$122.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Veeva Systems Inc
NYSE:VEEV
|
Operating Expenses
-$1.3B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-30%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Operating Expenses
-$595.4m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Operating Expenses
-$425.7m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Operating Expenses
-$252.9m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Operating Expenses
-$708.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
See Also
What is Pear Therapeutics Inc's Operating Expenses?
Operating Expenses
-122.5m
USD
Based on the financial report for Dec 31, 2022, Pear Therapeutics Inc's Operating Expenses amounts to -122.5m USD.
What is Pear Therapeutics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 1Y
-17%
Over the last year, the Operating Expenses growth was -17%.